Outcome Resources Inc.

1-866-877-2053

 Pharmacy Benefits Management

The Hospice Clinician Blog

Subscribe to Blog:

Search:



ABH Gel  Acetaminophen  acetaminophen  acid suppression. ranitidine  aclidinium bromide  acute phosphate nephropathy  adverse drug events  Agitation  albuterol  aliskiren  allergy  alprazolam  Alzheimer's  Alzheimers  Ambien  Amitiza  and Methadone (Dolophine)  Angina  anorexia  antibiotics  Anticholinergics  anticoagulation  antiplatelet  antipsychotic  antipsychotics  appetite  Arcapta Neohaler  Aricept  arrhythmia  aspirin  asthma  Ativan  Avastin  Avinza  Azithromycin  azithromycin  Baclofen  barbiturates  Beers Criteria  Beers List  Benzodiazepines  benzodiazepines  Beta‐2 Agonists  bexarotene  bone metastases  bone pain  Boniva  bowel movement  breakthrough pain  Breo Ellipta  brochodilator  Buprenorphine  BuprenorphinePranay Parihar  cancer pain  Cardiac Arrhythmia  cardiovascular  Celexa  Chlorpromazine (Thorazine)  Choosing Wisely  Cimetidine  Citalopram  Citalopram (Celexa)  CMS  codeine  colace  Combivent  Combivent Respimat  compounded medication  constipation  controlled prescriptions  controlled substance  COPD  Coronary Artery Disease  corticosteroid  Coumadin  counterfeit drugs  dabigatran  Darvocet  Darvon  DEA  Delirium  dementia  depression  Diazepam  docusate  Doxepin  drug disposal  drug shortage  drug shortages  dry powder inhaler  dyspnea  Edluar  Endo  Endocet  Endodan  enema  escitalopram  Escitalopram (Lexapro)  esophagitis  eszopiclone  ethics  Exalgo  Exelon  famotidine  faxing prescriptions  FDA  FDA REMS  fentanyl  fentanyl sublingual spray  first-generation antihistamines  fleet enema  flu vaccine  Gastroesophageal reflux disease  Gastrointestinal  generic  generic Lexapro  generic Seroquel  generics  GERD  H2RA  haloperidol  Haloperidol (Haldol)  Heart  Heart Failure  hiccups  hospice  Hospice Action Network  hospice advocacy  hospice ceu  hospice clinical  hospice clinical support  hospice compliance  hospice Conditions of Participation  hospice constipation  hospice COP  hospice CoP compliance  hospice cough  hospice docusate  hospice drug  hospice drug choice  hospice drug disposal  hospice drug dosage  Hospice Drugs  hospice drugs  hospice drugs,delirium,haloperidol,haldol,antipsychotics  hospice education  hospice education programs  hospice medication  Hospice Medication Chart  hospice medication disposal  hospice medication orders  hospice medication review  Hospice Medications  hospice methadone  hospice opioid conversion  hospice opioids  hospice pain management  hospice patient  hospice patient care  hospice PBM  hospice pbm  hospice PBM choice  hospice pharmacist  hospice pharmacy  hospice pharmacy benefit manager  hospice pharmacy decision  hospice seizure  hospice symptom management  hospira carpuject  Hydrocodone  hydrocodone  hydrocodone/APAP  hydrocodone/APAP recall  hydromorphone  hydromorphone recall  hypoglycemics  IBS  incomplete cross-tolerance  influenza  Inhaled Corticosteroids  inhaler  inhaler technique  INR  Insomnia  insomnia  Intermezzo  ipratropium  irritable bowel  Kadian  ketamine  kidney disease  laxative  Lazanda  leg cramps  leukotriene-receptor antagonist  Linaclotide  Lipitor  long acting opioids  Lorazepam  Lortab  lovastatin drug interactions  low dose aspirin  LTRA  Lubiprostone  Lunesta  lung cancer  medical marijuana  Medicare Part D  medication adherence  medication allergy  medication disposal  medication orders  medication review  medication shortage  medication tapering  Megace  Meningitis  meperidine  metered dose inhaler  Methadone  methadone dosage  Methylprednisolone  methyphenidate  Metoclopramide  Midazolam  morphine  morphine injection recall  morphine sulfate  multiple sclerosis  muscle relaxants  naproxen  narcotic  nausea  NHPCO  Nitrate  nitrofurantoin  Nitroglycerin  NSAID  OIG  olanzapine  omeprazole  ondansetron hydrochloride  Opana  Opana ER  opioid  opioid allergy  opioid disposal  opioid induced constipation  opioid-induced constipation  opioids  overactive bladder  Oxybutynin  Oxycodone  oxycodone  Oxycontin  oxycontin  oxymorphone  oxytrol  palliative care  Parkinson's  patient compliance  PBM decision  pediatric  pediatric end of life care  pediatric hospice  pediatric hospice care  pediatric palliative  pediatric palliative care  pediatric palliative symptom management  Pepcid  peptic ulcer disease  Percocet  Percodan  PPI  PPIs  Pradaxa  Product Information  Propoxyphene  Prostate Cancer  Proton Pump Inhibitor  Proton Pump Inhibitors  pruritis  QT interval  QT Prolongation  quetiapine  quinine  Recall  Reglan  Relistor  renal impairment  research  respiratory medications  Revatio  Risperidone  risperidone  Roflumilast  Ropinirole  Salonpas  Sativex  Schedule II  schedule II medications  scheduled medications  Scopolamine  sennosides  Seroquel  Silenor  Singulair  Sonata  Spiriva  Sprix  START and STOPP  statins liver function  statins safety  statins side effects  stool softener  stroke  Sublingual Nitroglycerin  subsys  sulfa allergy  Tagamet  Targretin  targretin  TdP  tertiary TCAs  tiotropium  TIRF REMS Access Program  Transderm Scop  transmucosal immediate-release fentanyl  Tudorza Pressair  Tylenol  tylenol  Valium  Versed  Vicodin  vicodin  vitamin K  warfarin  writing orders  zaleplon  Zantac  zithromax  Zofran  Zolpidem  zolpidem  Zolpimist  Zydone  Zyprexa 

08/16/2011

Update on Opioid Risk Evaluation and Mitigation Strategies

The Food and Drug Administration Amendments Act of 2007 gave the FDA the authority to require manufacturers to develop and implement a Risk Evaluation and Mitigation Strategy (REMS), for any drug at any time, whenever the FDA deems such action is necessary to ensure the benefits of a drug outweigh its risks. Extended-release (ER) and long-acting (LA) opioids are one medication class upon which the FDA has focused its attention because of steadily rising rates of opioid misuse, abuse, and accidental overdose.

Now, government regulation of the prescribing of ER and LA opioids has been expanded. On April 19, 2011 the Office of National Drug Control Policy (ONDCP) released the Obama Administration’s “Epidemic: Responding to America’s Prescription Drug Abuse Crisis” plan. The plan is part of the White House's first national action plan to fight prescription drug abuse. The ONDCP, the DEA, and the FDA are banding together to address the problem they say has become "an epidemic."

DOWNLOAD OUR COMPLETE UPDATE ON OPIOID REMS

Tags: hospice opioids, FDA REMS, hospice, hospice drugs, hospice pharmacist, FDA

Downloads:  

9705clinician_newsletter_july2011.pdf

First 10 <<Previous 10 Next 10 >> Last 10

 

 


Education Resources and Support for Hospices

Stay up-to-date on the latest hospice pharmacy benefits management information and tools with a variety of education resources and support at no extra charge. We offer presentations live at your facility, over the Internet or viaEducational Resources and Support for Hospicesteleconference, online service education programs, customized courses, and courses accredited for nursing continuing education credit.

See all of our educational resources>>

Clinical hospice and palliative cae consultation

Clinical Services

Our palliative care experts provide clinical consulting on important medication management and care decisions. Our non-dispensing pharmacists provide focused attention and unbiased advice.

 

Read more about our clinical pharmacy benefits management services>>

Why Use A PBM?

Contracting with multiple pharmacies, doing all the reporting, trying to stay current with medical practices and stay compliant while keeping costs down? There’s an easier and more effective way.

Find out how using a pharmacy benefits manager (PBM) can help you>>

Why Use a PBM